A new trading day began on Friday, with Soleno Therapeutics Inc (NASDAQ: SLNO) stock price up 1.55% from the previous day of trading, before settling in for the closing price of $80.32. SLNO’s price has ranged from $41.50 to $90.32 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 20.19% over the past five years. Meanwhile, its annual earnings per share averaged 45.35%. With a float of $41.76 million, this company’s outstanding shares have now reached $48.53 million.
Let’s look at the performance matrix of the company that is accounted for 92 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Soleno Therapeutics Inc (SLNO) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Soleno Therapeutics Inc is 17.13%, while institutional ownership is 94.20%. The most recent insider transaction that took place on Jul 01 ’25, was worth 316,971. In this transaction an insider of this company sold 3,830 shares at a rate of $82.76, taking the stock ownership to the 13,206 shares. Before that another transaction happened on Jul 01 ’25, when Company’s Officer proposed sale 3,830 for $82.76, making the entire transaction worth $316,971.
Soleno Therapeutics Inc (SLNO) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 45.35% per share during the next fiscal year.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
Here are Soleno Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 19.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.62, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach 1.72 in one year’s time.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Soleno Therapeutics Inc (NASDAQ: SLNO) saw its 5-day average volume 2.2 million, a positive change from its year-to-date volume of 1.04 million. As of the previous 9 days, the stock’s Stochastic %D was 34.13%.
During the past 100 days, Soleno Therapeutics Inc’s (SLNO) raw stochastic average was set at 81.50%, which indicates a significant increase from 26.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.66 in the past 14 days, which was higher than the 3.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $78.48, while its 200-day Moving Average is $59.23. Nevertheless, the first resistance level for the watch stands at $82.96 in the near term. At $84.35, the stock is likely to face the second major resistance level. The third major resistance level sits at $85.50. If the price goes on to break the first support level at $80.42, it is likely to go to the next support level at $79.27. Assuming the price breaks the second support level, the third support level stands at $77.88.
Soleno Therapeutics Inc (NASDAQ: SLNO) Key Stats
With a market capitalization of 4.11 billion, the company has a total of 50,394K Shares Outstanding. Currently, annual sales are 0 K while annual income is -175,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -43,770 K.
